Request Legal Help Now - Free
LAWSUITS NEWS & LEGAL INFORMATION

Byetta Legal News Articles & Interviews

View Lawyer Interviews only

Big Trial Coming for Diabetes Drug Byetta

Big Trial Coming for Diabetes Drug Byetta September 23, 2013. By Brenda Craig.
Los Angeles, CA: More than seven million prescriptions have been written in the US for a diabetes drug called Byetta, and this coming November, all eyes will focus on a California court case that alleges that its use triggered acute pancreatitis in five individuals and led to the death of two others.
Read [ Big Trial Coming for Diabetes Drug Byetta ]

Doctor Knew of Problems with Januvia in 2008

Doctor Knew of Problems with Januvia in 2008 June 5, 2013. By Lucy Campbell.
Washington, DC: Merck, the maker of sitagliptin (Januvia, Janumet, Janumet XR, Juvisync), is, according to The New York Times, facing 43 personal injury lawsuits alleging Januvia caused pancreatic cancer. But Merck is not the only pharmaceutical company facing legal action over adverse event profiles associated with this class of drugs: over 100 lawsuits claiming injury from Byetta, mostly pancreatitis, according to the latest quarterly regulatory filing from Bristol-Myers.
Read [ Doctor Knew of Problems with Januvia in 2008 ]

Januvia and Byetta Increase Pancreatic and Neuroendocrine Cancer Risk

Januvia and Byetta Increase Pancreatic and Neuroendocrine Cancer Risk April 1, 2013. By Lucy Campbell.
Washington, DC Results from a small study of organs from diabetic patients who were treated with Merck’s Januvia (sitagliptin) and Bristol-Myers Squibb’s Byetta and Bydureon (exenatide) show increases in pancreatic mass and beta cell mass, potentially increasing their risk for pancreatic cancer.
Read [ Januvia and Byetta Increase Pancreatic and Neuroendocrine Cancer Risk ]

FDA Opens Investigation into Januvia and Pancreatitis

FDA Opens Investigation into Januvia and Pancreatitis March 25, 2013. By Lucy Campbell.
Washington, DC Reports of pancreatitis associated with type 2 diabetes medications, including Merck’s Januvia and Bristol-Myers Squibb’s Byetta and Bydureon, have prompted the Food and Drug Administration (FDA) to begin a safety review.
Read [ FDA Opens Investigation into Januvia and Pancreatitis ]

FDA Launches New Evalution into Link Between Type 2 Diabetes Meds and Pancreatitis

FDA Launches New Evalution into Link Between Type 2 Diabetes Meds and Pancreatitis March 14, 2013. By Lucy Campbell.
Washington, DC Several recently approved diabetes medications, including Januvia and Janumet (Merck), Victoza (Novo Nordisk) and Byetta and Bydureon (Bristol-Myers Squibb), have come under new review by the Food and Drug Administration (FDA), as a result of emerging evidence which suggests these drugs increase the risk for pancreatitis.
Read [ FDA Launches New Evalution into Link Between Type 2 Diabetes Meds and Pancreatitis ]

Januvia Studies Link Medication to Serious Side Effects

Januvia Studies Link Medication to Serious Side Effects March 8, 2013. By Heidi Turner.
Miami, FL A new study examining Januvia has some critics arguing that patients should talk to their doctor about the risk of Januvia side effects. Although no Januvia lawsuits have been filed, Ben Stewart, attorney at Stewart Law Group PLLC, says he expects lawsuits will be filed in the next few months, alleging patients suffered serious side effects - including thyroid and pancreatic cancer- as a result of using Januvia.
Read [ Januvia Studies Link Medication to Serious Side Effects ]

Pancreatitis Risk Doubles with Januvia and Byetta JAMA Study Shows

Pancreatitis Risk Doubles with Januvia and Byetta JAMA Study Shows February 26, 2013. By Lucy Campbell.
Washington, DC Results from a new study of the diabetes treatments Januvia and Byetta show that the drugs may double the risk of pancreatitis. While both drugs have been associated with pancreatitis, new data reported in JAMA Internal Medicine finally reveal an estimate of the risk.
Read [ Pancreatitis Risk Doubles with Januvia and Byetta JAMA Study Shows ]

New Owners Gambling Bydureon Won’t Be Another Byetta

New Owners Gambling Bydureon Won’t Be Another Byetta August 12, 2012. By Gordon Gibb.
New York, NY When Bristol-Myers Squibb (Squibb) and AstraZeneca close the deal on their acquisition of Amylin Pharmaceuticals, the suitors will not only rake in the cash from Amylin's new once-weekly diabetes drug injectable Bydureon, they will also have to assume any perceived and demonstrated risks associated with both Bydureon and Byetta. The latter has been linked to various side effects, including Byetta acute pancreatitis and kidney problems.
Read [ New Owners Gambling Bydureon Won’t Be Another Byetta ]

FDA Accuses Amylin of Withholding Byetta Safety Information

FDA Accuses Amylin of Withholding Byetta Safety Information July 7, 2012. By Heidi Turner.
Washington, DC A recently posted memo from the US Food and Drug Administration (FDA) accuses Amylin Pharmaceuticals of withholding information about the safety of Byetta, a diabetes medication. The memo, written concerning an application for Bydureon, claims Amylin withheld information about Byetta side effects, information that was uncovered during a study conducted for Canadian regulatory authorities. Byetta has been linked to a number of serious side effects, including acute pancreatitis.
Read [ FDA Accuses Amylin of Withholding Byetta Safety Information ]

What Can Patients Believe About Byetta?

What Can Patients Believe About Byetta? June 1, 2012. By Heidi Turner.
San Diego, CA Byetta, the diabetes medication made and marketed by Eli Lilly and Amylin, has reportedly been linked to an increased risk of pancreatitis and pancreatic cancer. Some of these reported Byetta side effects may go under the radar, however, because the makers of the drug—and similar drugs—disputed some of the scientific research that went against their medication. The pharmaceutical companies argued that other studies did not find an increased risk of serious side effects and further did not find an association between Byetta and certain reported risks.
Read [ What Can Patients Believe About Byetta? ]

Request Legal Help Now! - Free